| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 32,500 | 20 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:07 |
| CCCC | C4 Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 16:22 |
| CCCC | C4 Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 23 Jun 2022, 16:15 |
| CCCC | C4 Therapeutics, Inc. | 04 Jan 2022 | 1 | +$13,516 | 4 | Director | 18 Jan 2022, 15:30 |
| CCCC | C4 Therapeutics, Inc. | 17 Dec 2021 | 1 | -$22,839 | 4 | Director | 17 Dec 2021, 15:28 |
| CCCC | C4 Therapeutics, Inc. | 19 Nov 2021 | 1 | -$30,283 | 4 | Director | 19 Nov 2021, 15:30 |
| CCCC | C4 Therapeutics, Inc. | 15 Oct 2021 | 1 | -$33,930 | 4 | Director | 15 Oct 2021, 16:36 |
| CCCC | C4 Therapeutics, Inc. | 04 Oct 2021 | 1 | +$13,497 | 4 | Director | 05 Oct 2021, 16:56 |
| CCCC | C4 Therapeutics, Inc. | 17 Sep 2021 | 1 | -$37,667 | 4 | Director | 21 Sep 2021, 19:25 |
| CCCC | C4 Therapeutics, Inc. | 20 Aug 2021 | 1 | -$30,751 | 4 | Director | 24 Aug 2021, 17:01 |
| CCCC | C4 Therapeutics, Inc. | 16 Jul 2021 | 1 | -$28,214 | 4 | Director | 19 Jul 2021, 16:30 |
| CCCC | C4 Therapeutics, Inc. | 02 Jul 2021 | 1 | +$13,465 | 4 | Director | 07 Jul 2021, 16:30 |
| CCCC | C4 Therapeutics, Inc. | 18 Jun 2021 | 1 | -$28,078 | 4 | Director | 21 Jun 2021, 20:23 |
| CCCC | C4 Therapeutics, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 16:15 |
| CCCC | C4 Therapeutics, Inc. | 21 May 2021 | 1 | -$28,026 | 4 | Director | 24 May 2021, 18:42 |